Release of generic AXERT tabletsBarr filed its ANDA comprising a paragraph IV qualification for a generic Entocort EC item with the U.S. Food & Medication Administration in January 2008. Pursuing receipt of the see from the FDA that Barr’s ANDA have been accepted for submitting, Barr notified the brand new Drug Program and patent holder. ON, MAY 22, 2008, AstraZeneca filed match in the U.S. District Courtroom for the District of Delaware to avoid Barr from proceeding with the commercialization of its item. This step formally initiates the patent problem process beneath the Hatch-Waxman Act.‘In drug development, it's simpler to turn that growth function off than it is to switch on the cell's defective tumor suppression system.’.

Catalent Pharma to deliver Digimarc’s Media Enhanced Packing solutions Digimarc Corporation has licensed its mobile visual search software program to New Jersey-based Catalent Pharma Solutions, a respected provider of innovative packaging answers to the pharmaceutical, biotechnology, and consumer healthcare sectors. The agreement allows Catalent to deliver new Media Improved Packing solutions to its clients worldwide that may instantly connect customers to a variety of network solutions from printed product packaging, inserts, and labels using wise phones and various other digital devices. We think that dealing with Digimarc will uniquely placement us to aid the pharmaceutical and customer packaging industries to raised inform and engage the customers of their products.